Active Shortage

JAMP TELMISARTAN-HCT

JAMP PHARMA CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of JAMP TELMISARTAN-HCT in Canada?

Yes. JAMP TELMISARTAN-HCT 25MG 80MG has an active shortage reported to Health Canada (last updated September 22, 2026).

Why is JAMP TELMISARTAN-HCT not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will JAMP TELMISARTAN-HCT be available again?

The manufacturer's estimated resolution date is November 27, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Expected resolution~2 months remaining (estimate)

Affected strength25MG 80MG

Last updated2026-09-22

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

Jamp Telmisartan-HCT tablet

Jamp Telmisartan-HCT tablet; Out-of-Specification (Assay)

Type II2024-09-11

Moderate health risk

Possible match — not confirmed

JAMP TELMISARTAN-HCT

JAMP TELMISARTAN-HCT: Affected lots may contain higher dosage than the labelled dose

Type II2024-01-24

Moderate health risk

Possible match — not confirmed

DIN

02389959

Strength

25MG 80MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

HYDROCHLOROTHIAZIDE TELMISARTAN

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-09-22

Active Shortage

Disruption of the manufacture of the drug.

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

AMLODIPINE

2.5MG · DIN 02492199

AMLODIPINE

10MG · DIN 02429225

AMLODIPINE

5MG · DIN 02429217